NetherlandsSep. 12, 2025 4:16 AM ETargenx SE (ARGX) Stock, ARGNF StockARGX, ARGNFThe Global Investor1.94K Followersargenx's blockbuster Vyvgart drives rapid growth, but heavy reliance on one product and US sales creates concentration risk.The company's robust R&D investment and Immunology Innovation Program fuel a strong pipeline, with empasiprubart showing promising diversification potential.Risks include intense competition, potential loss of exclusivity, and US pricing policy changes, but argenx's large cash reserves provide a solid runway.Despite a premium valuation, I believe argenx offers a compelling long-term opportunity for investors willing to accept biotech sector risks.Orhan Turan/iStock via Getty Imagesargenx SE (NASDAQ:ARGX) is a Dutch biotechnology company specializing in the development of therapeutic antibodies for the treatment of diseases. The company has a strong focus on research and development and has shown strongThis article was written byThe Global Investor1.94K FollowersGlobal investing.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in ARGX over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.CommentsRecommended For You